Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 72971 SAN FRANCISCO, CA
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$124,981
+$86,840 QoQ
Shares Held
23,806
+132.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. LFCR ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in LFCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $124,981 23,806
2026-03-31 $38,141 10,253
2025-12-31 $251,592 30,757
2025-09-30 $133,400 18,125
2025-06-30 $123,610 15,223
2025-03-31 $106,522 15,131
2024-12-31 $99,420 13,381
2024-09-30 $51,119 10,369
2024-06-30 $58,024 11,311
2024-03-31 $11,400 2,147
2023-12-31 $13,270 2,144
2023-09-30 $16,111 2,134
2023-06-30 $20,673 2,138
2023-03-31 $24,963 6,604
2022-12-31 $12,636 1,950
2022-09-30 $17,895 2,013
2022-06-30 $22,770 2,284
2022-03-31 $302,400 26,114
2021-12-31 $599,289 53,990
2021-09-30 $825,069 89,487
2021-06-30 $318,430 28,305
2021-03-31 $815,361 76,921
2020-12-31 $876,873 80,818
2020-09-30 $775,587 79,793
2020-06-30 $688,443 86,488
2020-03-31 $653,469 75,198